家畜用医薬品市場：薬効、投与経路、家畜動物、流通チャネル別-2025-2030年の世界予測

家畜用医薬品市場は、2023年に169億2,000万米ドルと評価され、2024年には179億2,000万米ドルに達すると予測され、CAGR 5.60％で成長し、2030年には247億8,000万米ドルに達すると予測されています。

家畜用医薬品には、医薬品、ワクチン、飼料添加物、その他家畜の健康と生産性を維持・向上させるための健康食品が含まれます。この分野は、動物由来製品に対する世界の需要の高まりに対応するために不可欠であり、家畜ヘルスケア手法の進歩が必要とされています。用途は、ワクチン接種プログラムなどの予防措置から、家禽、牛、豚、その他の家畜に罹患する疾病に対処する治療薬まで多岐にわたる。最終用途には、農場、動物病院、動物ケアセンターなどが含まれます。市場成長の原動力となっているのは、肉や乳製品の消費量の増加、獣医療技術の進歩、動物の健康に対する意識の高まり、家畜福祉を支援する規制の枠組みなどです。新興市場における急速な都市化と所得の増加は、高品質な畜産物への需要をさらに高め、大きな成長機会となります。しかし、厳しい規制、開発コストの高さ、抗生物質耐性に関する問題など、課題も残っています。原料価格の変動や新興の人獣共通感染症は、市場力学に複雑さを加えています。新規ワクチンの開発、精密畜産技術、プロバイオティクスや植物由来の添加物といった抗生物質の代替品といった分野では、イノベーションが盛んになる可能性があります。製薬会社と農業関連企業との戦略的提携はシナジーを生み出し、製品の提供や流通チャネルを強化することができます。潜在的な機会を活用するため、利害関係者は持続可能な解決策を目指した研究開発投資に注力し、製品承認を迅速化するために規制機関との透明性の高いコミュニケーションを優先すべきです。さらに、疾病の予測モデリングや治療計画のカスタマイズにデータ分析を活用することで、動物の健康管理を大幅に最適化することができます。これらのイノベーションの道筋に集中し、戦略的計画とコラボレーションを通じて既存の課題を克服することで、市場参入企業は家畜用医薬品市場における既存および新たな機会を効果的に活用することができます。

市場力学：急速に進化する家畜用医薬品市場の主要市場インサイトを公開

家畜用医薬品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の家畜頭数の増加
  • 家畜伝染病の発生
  • 家畜のワクチン使用量の増加
• 市場抑制要因
  • 発展途上地域における家畜用医薬品の入手可能性と認知度の制限
  • 偽造薬や規格外薬の存在
• 市場機会
  • 家畜の健康と福祉に対する意識の高まり
  • 畜産業界への投資の急増
  • 新規家畜用医薬品開発のための研究開発
• 市場の課題
  • 家畜における抗菌薬耐性の増加
  • 投薬による家畜への悪影響の可能性

ポーターのファイブフォース家畜用医薬品市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：家畜用医薬品市場における外部からの影響の把握

外部マクロ環境要因は、家畜用医薬品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析家畜用医薬品市場における競合情勢の把握

家畜用医薬品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス家畜用医薬品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、家畜用医薬品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨家畜用医薬品市場における成功への道筋を描く

家畜用医薬品市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界の家畜頭数の増加
    • 家畜伝染病の発生状況
    • 家畜におけるワクチン使用の増加
  • 抑制要因
    • 発展途上地域では家畜用医薬品の利用可能性と認知度が限られている
    • 偽造医薬品や不良医薬品の存在
  • 機会
    • 家畜の健康とウェルネスに対する意識の向上
    • 畜産業界への投資急増
    • 新規家畜医薬品開発の研究開発
  • 課題
    • 家畜における抗菌薬耐性の増加
    • 家畜に対する薬剤の潜在的な悪影響
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 家畜用医薬品市場薬別

• 薬物
  • 抗感染薬
  • 抗炎症
  • 駆虫薬
• 医薬品添加飼料添加物
  • アミノ酸
  • 抗生物質
  • 抗酸化物質
  • 酵素
  • プレバイオティクスとプロバイオティクス
  • ビタミン
• ワクチン
  • 不活化ワクチン
  • 弱毒生ワクチン

第7章 家畜用医薬品市場：投与経路別

• 注射可能
• オーラル
• 話題

第8章 家畜用医薬品市場家畜別

• 牛
• 魚
• 家禽
• 豚

第9章 家畜用医薬品市場流通チャネル別

• オフライン
  • 薬局
  • 獣医クリニック
• オンライン

第10章 南北アメリカの家畜用医薬品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の家畜用医薬品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの家畜用医薬品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Biogenesis Bago SA
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Inc.
• HESTER BIOSCIENCES LIMITED
• Indian Immunologicals Ltd.
• Merck & Co., Inc.
• Neogen Corporation
• Nutreco N.V.
• Phibro Animal Health Corporation
• Vetoquinol S.A.
• Vetpharma Animal Health S.L.
• Virbac SA
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. LIVESTOCK MEDICINE MARKET RESEARCH PROCESS
• FIGURE 2. LIVESTOCK MEDICINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. LIVESTOCK MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. LIVESTOCK MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. LIVESTOCK MEDICINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. LIVESTOCK MEDICINE MARKET DYNAMICS
• TABLE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIOXIDANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY KILLED INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MODIFIED LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 65. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 66. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 67. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 68. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 69. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 71. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 72. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 77. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 78. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 79. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 80. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 86. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 87. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 88. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 89. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 94. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 96. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 98. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 100. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 101. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 102. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 103. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 104. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 105. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 106. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 107. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 108. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 109. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 110. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 111. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 112. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 113. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 114. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 115. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 116. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 117. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 118. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 119. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 120. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 121. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 122. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 123. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 124. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 125. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 126. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 127. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 128. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 129. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 130. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 131. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 132. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 133. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 134. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 135. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 136. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 137. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 138. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 139. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 140. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 141. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 142. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 143. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 144. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 145. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 146. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 147. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 148. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 149. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 150. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 151. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 152. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 153. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 154. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 155. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 156. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 157. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 158. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 159. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 160. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 161. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 162. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 171. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 172. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 173. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 174. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 175. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 176. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 177. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 178. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 179. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 180. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 181. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 182. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 183. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 184. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 185. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 186. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 187. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 188. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 189. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 190. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 191. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 192. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 193. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 194. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 204. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 205. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 206. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 207. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 208. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 209. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 210. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 211. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 212. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 213. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 214. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 215. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 216. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 217. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 218. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 219. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 220. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 221. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 222. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 223. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 224. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 225. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 226. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 227. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 228. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 229. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 230. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 231. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 232. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 233. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 234. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 235. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 236. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 237. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 238. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 239. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 240. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 241. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 242. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 243. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 244. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 245. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 246. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 247. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 248. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 249. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 250. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 251. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 252. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 253. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 254. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 255. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 256. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 257. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 258. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 259. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 260. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 261. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 262. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 263. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 264. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 265. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 266. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 267. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 268. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 269. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 270. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 271. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 272. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 273. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 274. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 275. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 276. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 277. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 278. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 279. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 280. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 281. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 282. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 283. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 284. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 285. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 286. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 287. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 288. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 289. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 290. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 291. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 292. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 293. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 294. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 295. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 296. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 297. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 298. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 299. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 300. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 301. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 302. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 303. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 304. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 305. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 306. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 307. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 308. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 309. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 310. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 311. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 312. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 313. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 314. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 315. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 316. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 317. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 318. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 319. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 320. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 321. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 322. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 323. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 324. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 325. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 326. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 327. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 328. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 329. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 330. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 331. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 332. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 333. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 334. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 335. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 336. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 337. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 338. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 339. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 340. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
• TABLE 341. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 342. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
• TABLE 343. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 344. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 345. SWITZERLAND LIVESTOCK MEDICINE MARKET S

The Livestock Medicine Market was valued at USD 16.92 billion in 2023, expected to reach USD 17.92 billion in 2024, and is projected to grow at a CAGR of 5.60%, to USD 24.78 billion by 2030.

Livestock medicine encompasses pharmaceuticals, vaccines, feed additives, and other health products designed to maintain and enhance the health and productivity of farm animals. This sector is critical for fulfilling the rising global demand for animal-derived products, necessitating advancements in livestock healthcare practices. Applications range from preventive measures, such as vaccination programs, to therapeutics addressing diseases that affect poultry, cattle, swine, and other livestock. The end-use scope includes farms, veterinary hospitals, and animal care centers. Market growth is driven by rising consumption of meat and dairy products, technological advancements in veterinary care, increased awareness of animal health, and regulatory frameworks supporting livestock welfare. Rapid urbanization and income growth in emerging markets further fuel demand for quality animal products, presenting significant opportunities. Yet, challenges persist, notably stringent regulations, high costs of development, and issues related to antibiotic resistance. The volatility of raw material prices and emerging zoonotic diseases add complexity to market dynamics. Innovation can thrive in areas like the development of novel vaccines, precision livestock farming technologies, and alternatives to antibiotics such as probiotics and plant-based additives. Strategic alliances between pharma companies and agricultural entities can create synergies, enhancing product offerings and distribution channels. To harness potential opportunities, stakeholders should focus on R&D investments aimed at sustainable solutions and prioritize transparent communication with regulatory bodies to expedite product approvals. Additionally, leveraging data analytics for predictive disease modeling and customizing treatment plans can significantly optimize animal health management. By concentrating on these innovation avenues and overcoming existing challenges through strategic planning and collaboration, market participants can effectively capitalize on existing and emerging opportunities in the livestock medicine market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Livestock Medicine Market

The Livestock Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growth in livestock population globally
  • Incidences of livestock infectious diseases
  • Rising usage of vaccines among livestock
• Market Restraints
  • Limited availability and awareness of livestock medicine in developing areas
  • Presence of counterfeit or substandard drugs
• Market Opportunities
  • Increasing awareness for livestock health & wellness
  • Surge in investment in the livestock industry
  • R&D for novel livestock drug development
• Market Challenges
  • Rise in antimicrobial resistance in livestock
  • Potential adverse impact of medication on livestock

Porter's Five Forces: A Strategic Tool for Navigating the Livestock Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Livestock Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Livestock Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Livestock Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Livestock Medicine Market

A detailed market share analysis in the Livestock Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Livestock Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Livestock Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Livestock Medicine Market

A strategic analysis of the Livestock Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Livestock Medicine Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc., HESTER BIOSCIENCES LIMITED, Indian Immunologicals Ltd., Merck & Co., Inc., Neogen Corporation, Nutreco N.V., Phibro Animal Health Corporation, Vetoquinol S.A., Vetpharma Animal Health S.L., Virbac SA, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Livestock Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Medication, market is studied across Drugs, Medicated Feed Additives, and Vaccines. The Drugs is further studied across Anti-infectives, Anti-inflammatory, and Antiparasitic. The Medicated Feed Additives is further studied across Amino acids, Antibiotics, Antioxidants, Enzymes, Prebiotics & Probiotics, and Vitamins. The Vaccines is further studied across Killed Inactivated Vaccines and Modified Live Vaccines.
• Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
• Based on Livestock Animals, market is studied across Cattle, Fish, Poultry, and Swine.
• Based on Distribution Channels, market is studied across Offline and Online. The Offline is further studied across Pharmacy and Veterinary Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growth in livestock population globally
    • 5.1.1.2. Incidences of livestock infectious diseases
    • 5.1.1.3. Rising usage of vaccines among livestock
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability and awareness of livestock medicine in developing areas
    • 5.1.2.2. Presence of counterfeit or substandard drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing awareness for livestock health & wellness
    • 5.1.3.2. Surge in investment in the livestock industry
    • 5.1.3.3. R&D for novel livestock drug development
  • 5.1.4. Challenges
    • 5.1.4.1. Rise in antimicrobial resistance in livestock
    • 5.1.4.2. Potential adverse impact of medication on livestock
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Livestock Medicine Market, by Medication

• 6.1. Introduction
• 6.2. Drugs
  • 6.2.1. Anti-infectives
  • 6.2.2. Anti-inflammatory
  • 6.2.3. Antiparasitic
• 6.3. Medicated Feed Additives
  • 6.3.1. Amino acids
  • 6.3.2. Antibiotics
  • 6.3.3. Antioxidants
  • 6.3.4. Enzymes
  • 6.3.5. Prebiotics & Probiotics
  • 6.3.6. Vitamins
• 6.4. Vaccines
  • 6.4.1. Killed Inactivated Vaccines
  • 6.4.2. Modified Live Vaccines

7. Livestock Medicine Market, by Route of Administration

• 7.1. Introduction
• 7.2. Injectable
• 7.3. Oral
• 7.4. Topical

8. Livestock Medicine Market, by Livestock Animals

• 8.1. Introduction
• 8.2. Cattle
• 8.3. Fish
• 8.4. Poultry
• 8.5. Swine

9. Livestock Medicine Market, by Distribution Channels

• 9.1. Introduction
• 9.2. Offline
  • 9.2.1. Pharmacy
  • 9.2.2. Veterinary Clinics
• 9.3. Online

10. Americas Livestock Medicine Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Livestock Medicine Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Livestock Medicine Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Biogenesis Bago SA
• 2. Boehringer Ingelheim International GmbH
• 3. Ceva Sante Animale
• 4. Dechra Pharmaceuticals PLC
• 5. Elanco Animal Health Inc.
• 6. HESTER BIOSCIENCES LIMITED
• 7. Indian Immunologicals Ltd.
• 8. Merck & Co., Inc.
• 9. Neogen Corporation
• 10. Nutreco N.V.
• 11. Phibro Animal Health Corporation
• 12. Vetoquinol S.A.
• 13. Vetpharma Animal Health S.L.
• 14. Virbac SA
• 15. Zoetis Inc.